Berberine Inhibits Inflammatory Response and Ameliorates Insulin Resistance in Hepatocytes

被引:92
作者
Lou, Tianjiong [2 ]
Zhang, Zhongai [2 ]
Xi, Zhilei [2 ]
Liu, Kang [1 ]
Li, Lin [1 ]
Liu, Baolin [1 ]
Huang, Fang [1 ]
机构
[1] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Medica, Nanjing 210009, Peoples R China
[2] Hosp Tradit Chinese Med Nanjing, Dept Gerontol, Nanjing 210001, Peoples R China
关键词
berberine; insulin resistance; inflammation; hepatocytes; NECROSIS-FACTOR-ALPHA; FREE FATTY-ACIDS; TYROSINE KINASE-ACTIVITY; TNF-ALPHA; GLUCOSE-METABOLISM; LIVER-REGENERATION; SKELETAL-MUSCLE; IKK-BETA; OBESITY; RECEPTOR;
D O I
10.1007/s10753-010-9276-2
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Berberine, a major isoquinoline alkaloid present in Chinese herb Rhizoma coptidis, is a potent inhibitor of inflammation and has anti-diabetic activity. This study aims to investigate effects of berberine on ameliorating insulin resistance and molecular mechanisms involved in HepG2 cells. Inflammatory responses and insulin resistance were induced by palmitate (PA) stimulation for 24 h. Treatment of berberine enhanced insulin-mediated glycogen synthesis and restored insulin inhibition of triglyceride secretion. Stimulation of PA resulted in IL-6 and TNF-alpha production in HepG2 cells, and antibody-neutralizing assay further confirmed that IL-6 and TNF-alpha were involved in the development of insulin resistance. Berberine effectively inhibited IL-6 and TNF-alpha production in a concentration-dependent manner, demonstrating its anti-inflammatory activity in hepatocytes. Meanwhile, PA-evoked inflammation impaired insulin signaling cascade and berberine improved insulin signaling cascade by modification of Ser/Thr phosphorylation of insulin receptor substrate-1(IRS-1) and downstream Akt (T308). Above results suggest that berberine improved insulin sensitivity in PA-stimulated hepatocytes and this regulation might relative with its anti-inflammatory activity.
引用
收藏
页码:659 / 667
页数:9
相关论文
共 42 条
[1]  
Baldeweg SE, 2000, EUR J CLIN INVEST, V30, P45
[2]   Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].
Boden, G .
DIABETES, 1997, 46 (01) :3-10
[3]   Rates of skeletal muscle and adipose tissue glycerol release in nonobese and obese subjects [J].
Bolinder, J ;
Kerckhoffs, DAJM ;
Moberg, E ;
Hagström-Toft, E ;
Arner, P .
DIABETES, 2000, 49 (05) :797-802
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB [J].
Cai, DS ;
Yuan, MS ;
Frantz, DF ;
Melendez, PA ;
Hansen, L ;
Lee, J ;
Shoelson, SE .
NATURE MEDICINE, 2005, 11 (02) :183-190
[6]   Expression of suppressors of cytokine signaling during liver regeneration [J].
Campbell, JS ;
Prichard, L ;
Schaper, F ;
Schmitz, J ;
Stephenson-Famy, A ;
Rosenfeld, ME ;
Argast, GM ;
Heinrich, PC ;
Fausto, N .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (10) :1285-1292
[7]   Tumor necrosis factor-α induces hepatic insulin resistance in obese Zucker (fa/fa) rats via interaction of leukocyte antigen-related tyrosine phosphatase with focal adhesion kinase [J].
Cheung, AT ;
Wang, JF ;
Ree, D ;
Kolls, JK ;
Bryer-Ash, M .
DIABETES, 2000, 49 (05) :810-819
[8]   An in vivo model for elucidation of the mechanism of tumor necrosis factor-α (TNF-α)-induced insulin resistance:: Evidence for differential regulation of insulin signaling by TNF-α [J].
Cheung, AT ;
Ree, D ;
Kolls, JK ;
Fuselier, J ;
Coy, DH ;
Bryer-Ash, M .
ENDOCRINOLOGY, 1998, 139 (12) :4928-4935
[9]   Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte [J].
Choi, Bong-Hyuk ;
Ahn, In-Sook ;
Kim, Yu-Hee ;
Park, Ji-Won ;
Lee, So-Young ;
Hyun, Chang-Kee ;
Do, Myoung-Sool .
EXPERIMENTAL AND MOLECULAR MEDICINE, 2006, 38 (06) :599-605
[10]   Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity [J].
Dresner, A ;
Laurent, D ;
Marcucci, M ;
Griffin, ME ;
Dufour, S ;
Cline, GW ;
Slezak, LA ;
Andersen, DK ;
Hundal, RS ;
Rothman, DL ;
Petersen, KF ;
Shulman, GI .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :253-259